Application of new technology for precise radiotherapy of body tumor based on IGRT/SBRT

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900027548

Enrollment

Unknown

Registered

2019-11-17

Start date

2020-01-01

Completion date

Unknown

Last updated

2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body tumor

Interventions

Experimental group, Control group:Cumulative radiotherapy

Control group:Traditional radiotherapy

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Stage I NSCLC that refuses surgery; 2. Treatment of selective spinal cord and vertebral tumors; 3. Palliative treatment of recurrent tumors; 4. Palliative treatment of metastatic lesions (isolated liver/lung/adrenal metastasis) Treatment of the stove); 5. The estimated survival time is >6 months.

Exclusion criteria

Exclusion criteria: 1. Those with obvious mental abnormalities or intolerance to radiotherapy; 2. Those who are difficult to follow the doctor's advice to complete the relevant examinations and treatments; 3. Patients with advanced cancer with anemia, weight loss or cachexia.

Design outcomes

Primary

Measure	Time frame
OS;	—

Secondary

Measure	Time frame
PFS;ORR;DCR;	—

Countries

China

Contacts

Public ContactTianlu Wang

Liaoning Cancer Hospital

wangtianlu126@126.com+86 18900917511

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026